Insider Transactions Report

John E. Imhoff, a director and 10% owner of GUIDED THERAPEUTICS INC (GTHP), reported several transactions. On March 10, 2026, Imhoff acquired 110,000 stock options with a strike price of $0.29, vesting over time until March 10, 2029. On March 26, 2026, Imhoff converted 10 shares of Series F preferred stock into 40,000 shares of common stock. Additionally, 2,157 shares of common stock were acquired for accrued dividends on Series F preferred stock. On March 31, 2026, Imhoff converted $11,019.18 of a convertible promissory note into 157,417 shares of common stock at $0.07 per share. Following these transactions, Imhoff holds 21,252,673 shares of common stock directly, and $110,000 principal remains outstanding under the convertible note, which is convertible into common stock under certain conditions.